BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

BioSystems International Announces Appointment of a New CEO


3/12/2007 11:59:34 AM

EVRY, France--(BUSINESS WIRE)--BioSystems International ("BSI") is a French biotechnology company with research laboratories in France (Genopole Evry) and Hungary (University of Debrecen). BSI’s business is focused on the discovery and diagnostic development of biomarkers, based on its proprietary high throughput monoclonal antibody technology.

Prior to joining BSI, Jean Pierre Tirouflet was Chairman and CEO of the French specialty chemicals company Rhodia. He was Chief Financial Officer of Rhône Poulenc from 1986 to 1997 and member of its Executive Board from 1990 to 1999. Mr Tirouflet has been Chairman of the CEFIC (European Chemical Industry Council) from 2002 to 2004.

Formerly, he worked for the French Ministry of Finances, the French Representation to the EEC and the Crédit National . He is a graduate of France’s Ecole Nationale d’Administration.

About BioSystems International:

The mission of BioSystems International is to bring biomarkers to the bedside.

BioSystems International is a biotechnology company and is the industry leader in monoclonal antibody mediated biomarker discovery and diagnostics development. Its leading position in the field is secured by a proprietary, high throughput monoclonal antibody based platform that achieves biomarker discovery and the first level of validation in one step. It aims at bringing biomarkers to the bedside in record time and at delivering integrated and new companion diagnostics for the chronic diseases and cancer markets

BSI was founded in May 2004 by four internationally recognized American scientists, the Professors Barry Karger and William Hancock of Northeastern University of Boston, Professor Andras Guttman and Dr. Laszlo Takacs. Until May 2004, Dr. Takacs was Head of Pfizer’s former Fresnes Genomic and Bioinformatics laboratories. BSI’s core research team is staffed with scientists from Dr. Takacs’ prior Pfizer Fresnes group.

Since its founding, BSI has been principally financed by Societe Generale Asset Management by a grant from the Hungarian Ministry of Education.. www.biosys-intl.com

Contacts

BioSystems International

François Liebaert

+33 1 60 87 89 32 +33 6 85 32 93 58 francois.liebaert@biosys-intl.com

>>> Discuss This Story



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES